• market

  PRIVATE

• industry

  Biotechnology Research

• website

  visterrainc.com

• crunchbase

  visterra

Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Their proprietary technology platform enables the design and engineering of precision antibody-based product candidates that specifically bind to, and modulate, key disease targets.